Elspar

 

Topic mentions per year

Topic mentions per year

1987-2015
012319872015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
44 Current therapies for sarcomas are often inadequate. This study sought to 45 identify actionable gene targets by selective… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2012
2012
Hypersensitivity to asparaginase is common, but the differential diagnosis can be challenging and the diagnostic utility of… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2008
2008
Asparaginase (Elspar) is used in the treatment of acute lymphoblastic leukemia. It depletes plasma asparagine and glutamine… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2007
2007
On July 24, 2006, the U.S. Food and Drug Administration granted approval to pegaspargase (Oncaspar; Enzon Pharmaceuticals, Inc… (More)
Is this relevant?
2004
2004
Polyethylene glycol-conjugated (PEG) asparaginase is approved for use in patients who develop allergy to other forms of… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2004
2004
The crystal structure of Escherchia coli asparaginase II (EC 3.5.1.1), a drug (Elspar) used for the treatment of acute… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
1999
1999
Asparaginase (ASP) is a standard component of the antileukemia armamentarium. There are currently 3 preparations of asparaginase… (More)
Is this relevant?
1993
1993
The crystal structure of Escherichia coli asparaginase II (EC 3.5.1.1), a drug (Elspar) used for the treatment of acute… (More)
Is this relevant?
1987
1987
A 51-year-old black woman with diabetes mellitus developed severe hepatotoxicity after receiving high-dose L-asparaginase (Elspar… (More)
Is this relevant?